fDi Markets Newswire:

Our latest View From series coverage

View from BIO 2015

Date: June 15 - 18, 2015
Location: Philadelphia, USA

About 15,000 of biotech and pharmaceutical players from 65 countries are attending the 2015 BIO International Convention. fDi Magazine's deputy editor, Michal Kaczmarski, is reporting on the main topics of discussion and interview FDI and industry professionals.

View From BIO is your hub for the 2015 BIO International Convention, bringing you the latest coverage, FDI data and articles from the biotechnology industry.

Register here to receive daily updates from BIO 2015 and sign up to the fDi Intelligence e-newsletter.

On the right you will also find our View From series coverage of previous events.

BIO 2015 Preview

Biotechnology and pharmaceuticals FDI data

Between March 2010 and March 2015 a total of 1,395 FDI projects were recorded in the biotechnology and pharmaceuticals sectors. These projects represent a total capital investment of $52.92bn which is an average investment of $37.90m per project. During the period, a total of 130,532 jobs were created. 

BIO Headline figures

Trends spotted using fDi Markets, an online database tracking crossborder greenfield investment, covering all sectors and countries worldwide. Contact us for more information.

Related Articles

Little wonders
From Locations

Little wonders: how smaller cities are carving out an FDI niche

While the likes of London, Hong Kong and New York typically dominate the FDI tables, smaller cities find that they can punch above their weight by putting the focus on innovation and technology. Karen E Thuermer looks at how Fredericton, Lafayette, Heredia, Ghent, Eindhoven and Grenoble do it.

View from Europe: big pharma's big impact

Big pharma is big business in Europe, with initiatives such as the UK's Med City demonstrating why the region is the sector's number one trader.

View from Asia: a bigger, better pharmaceutical industry

Asia's pharmaceutical industry is growing at a rapid pace, with demand among its population increasing too. 

Thailand pharma

Thailand's new lease of life

Thailand's expertise in the life sciences sector has long remained under the radar, with a lack of investment preventing many of the discoveries from its scientific community making it to the commercial stage. But a government entity, the Thailand Centre for Excellence for Life Sciences, is looking to change this.


Biotech-pharma hotspots on the up

Locations are taking advantage of the growing demand for healthcare, bringing together academia, big industry, start-ups, hospitals and sources of capital to create thriving specialised biomedical-pharmaceutical clusters.